CooperCompanies, US21664P1039

CooperCompanies gains analyst support, shares hold near recent highs

25.06.2026 - 19:27:28 | ad-hoc-news.de

CooperCompanies stays in focus on Nasdaq after market commentary turned more constructive on earnings and valuation. Barclays and other analysts frame the shares around a Buy consensus and a price target near $81.

CooperCompanies, US21664P1039
CooperCompanies, US21664P1039

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 19:27.

CooperCompanies (US21664P1039) trades on Nasdaq as analysts keep the name under review. MarketBeat cites a mildly positive news flow, while the shares were last quoted at $70.16 in its Nasdaq coverage snapshot.

Analysts stay constructive

Public.com shows a Buy consensus from 12 analysts as of June 25, 2026, with a reported average target of $81.83. MarketBeat also highlights Barclays coverage and lists a $81.31 target, which puts the current quote below both figures.Public.com analyst consensus

That leaves the Nasdaq listing anchored in a clear research-house narrative. MarketBeat's Cooper Companies page shows a fair-value print of $70.85 and a market value of $13.82 billion, which keeps the stock close to the mid-$70s zone.MarketBeat coverage on Cooper Companies

What the numbers show

StockTitan says CooperCompanies announced second-quarter 2026 results and names June 24, 2026 as the latest price reference at $68.83. The same page also lists a second-quarter release and a CooperVision management change, adding two dated corporate markers for this week.StockTitan news overview

The wider setup still points to the same exchange anchor. Nasdaq remains the venue, and the company sits in the U.S. health-care equipment and supplies segment, where contact-lens and surgical-device peers often trade on earnings revisions and margin expectations.

Go deeper

All news and analysis on the CooperCompanies shares

The Nasdaq listing is shaped by earnings releases, analyst revisions, and the next CooperVision and CooperSurgical updates.

The product behind the stock

CooperVision sells soft contact lenses, while CooperSurgical covers women’s health and fertility products. That mix gives the group a consumer-facing lens business and a medical-device arm in one Nasdaq listing.

CooperCompanies at Nasdaq close

The CooperCompanies shares (US21664P1039) trade on 2026-06-25, 19:27 on Nasdaq at $70.16.

Key data on the CooperCompanies shares

  • Company: CooperCompanies, Inc.
  • ISIN: US21664P1039
  • Ticker: COO
  • Trading venue: Nasdaq
  • Price (as of 2026-06-25, 19:27): $70.16
  • Market cap: $13.82 billion
  • Sector / industry: Health Care Equipment & Supplies
  • Index membership: not verified in live sources
  • Next earnings date: not officially scheduled

More on the CooperCompanies shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | US21664P1039 | COOPERCOMPANIES | boerse | 69626433 | bgmi